Author： Müller T.
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.4, 2001-04, pp. : 557-572
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Drug treatment of non-motor symptoms in Parkinson’s disease
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 4, 2002-04 ,pp. :
Access to resources
Recommend
Dopaminergic substitution in Parkinson’s disease
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 10, 2002-10 ,pp. :
Existing dopaminergic therapies for Parkinson’s disease
By Dutta PhD Aloke K Le MD PhD Weidong
Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 12, 2006-12 ,pp. :
Ropinirole in the treatment of Parkinson’s disease
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. :